Wealth Effects LLC Immunity Bio, Inc. Transaction History

Wealth Effects LLC

$268 Million
Q3 2025

A detailed history of Wealth Effects LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Wealth Effects LLC holds 114,500 shares of IBRX stock, worth $238,160. This represents 0.1% of its overall portfolio holdings.

Number of Shares

114,500

Previous 122,000 6.15%

Holding current value

$238,160

Previous $322,000 12.73%

% of portfolio

0.1%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$2.24 - $3.01 $16,800 - $22,575	-7,500 Reduced 6.15%	114,500 $281,000
Q2 2025 Jul 15, 2025	BUY	$1.89 - $3.44 $44,415 - $80,840	23,500 Added 23.86%	122,000 $322,000
Q1 2025 Apr 23, 2025	BUY	$2.32 - $3.9 $57,535 - $96,720	24,800 Added 33.65%	98,500 $296,000
Q4 2024 Jan 22, 2025	SELL	$2.56 - $6.17 $43,008 - $103,656	-16,800 Reduced 18.56%	73,700 $188,000
Q3 2024 Oct 21, 2024	BUY	$3.32 - $6.7 $9,960 - $20,100	3,000 Added 3.43%	90,500 $335,000

Q2 2024 Aug 02, 2024	BUY	$4.82 - $9.15 $106,040 - $201,300	22,000 Added 33.59%	87,500 $553,000
Q1 2024 Apr 22, 2024	BUY	$3.23 - $6.17 $19,380 - $37,020	6,000 Added 10.08%	65,500 $351,000
Q4 2023 Jan 29, 2024	BUY	$1.25 - $5.21 $7,500 - $31,260	6,000 Added 11.21%	59,500 $298,000
Q3 2023 Oct 16, 2023	SELL	$1.29 - $3.1 $22,575 - $54,250	-17,500 Reduced 24.65%	53,500 $90,000
Q2 2023 Jul 18, 2023	BUY	$1.53 - $6.41 $65,025 - $272,425	42,500 Added 149.12%	71,000 $197,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $45,625 - $80,375	12,500 Added 78.13%	28,500 $142,000
Q2 2022 Aug 03, 2022	BUY	$2.68 - $6.14 $13,400 - $30,700	5,000 Added 45.45%	16,000 $60,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $55,550 - $82,830	11,000 New	11,000 $62,000

Others Institutions Holding IBRX

# of Institutions

297

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.

Account

Wealth Effects LLC Immunity Bio, Inc. Transaction History